DEBATE: Joseph Fraiman And Jay Bhattacharya On Pulling MRNA Vaccines Off The Market
Hi everyone,
Today on the podcast I debate with Joseph Fraiman on his HOPE Accord, a public petition to restore ethics to public health and to pull regulatory authorization for the marketing of the covid mRNA vaccine.
I hesitated to sign because I was concerned that some patient groups may still benefit from it. Joe, very reasonably, asked me how we could know who falls into those categories. The answer, of course, would come from randomized clinical trial evidence with solid clinical endpoints like prevention of long Covid, hospitalization, or death.
By the end of the debate, Joe had convinced me that not pulling the authorization makes it more likely that we will never get good clinical trial evidence testing to check whether such groups still exist in a setting of widespread recovered immunity.
Thanks to the debate, I now intend to sign the Accord. I appreciate Joe's willingness to help me think through the regulatory and policy matters. You can listen to the whole debate here on Spotify, Apple, and YouTube:
Ways to support The Illusion of Consensus:
Become a paid or founding member to receive early-access episodes and ask questions for future episodes.
Support The Illusion of Consensus with a donation
Subscribe to our YouTube and Rumble channels
Follow us on Apple podcasts and Spotify
 | A guest post by
|
“Long covid” is either vaccine injury (mostly), or possibly very occasional post-viral illness as has been observed to follow “flu” - likely to be much more common with months of military grade fear propaganda.
Thus the idea that it could be prevented by these products defies belief.
In any event, I can’t see that there would ever be a rational ethical basis for conducting a trial in healthy people of an injected genetic therapy, which, moreover, became widely distributed and was transported in a carrier which (by design) crossed all protective membranous barriers.
All norms of pharmaceutical development would require extensive testing to rule out harms to all target organs identified by bio distribution studies.
The target organs in this case are every single organ system.
The platform is inherently dangerous.
With all due respect, in what world could mRNA gene therapy be beneficial to "some patients"?? The delivery mechanism of a 2 part spike protein is designed to open the cell (any cell) through the ACE2 receptor, like a poison key in a lock. There are more of these receptors on male cells than female.
Once the delivery is complete the mRNA begins its work of changing the very structure of the cell, any cell. The nanolipid particle itself is delivering metals including graphene. (This lipid particle was invented in Vancouver, BC, at UBC, for a huge amount of money).
Not only is the recipient undergoing changes in her DNA, which will be permanent, she is thenceforward trackable, like metals to a magnet.
Find Henry Kissenger's comments on X to see how integrated a scheme like this has been to NATO/Pentagon planning! We have been skewered!